BioPorto A/S
BIOPOR
株式のランク
#22680
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
株価
$0.16512379
最終同期: 2026-10-16
時価総額
$81.75M
変化（1日）
-0.95%
変化（1年）
-42.67%
国
DK
取引 BioPorto A/S (BIOPOR)
カテゴリー
Healthcare
の時価総額 BioPorto A/S(BIOPOR)
時価総額: $81.75M
October 2026時点で、BioPorto A/S の時価総額は $81.75M です。これは、当社のデータによると、BioPorto A/S が世界で22680th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
BioPorto A/S の時価総額の履歴（2019 から 2026 まで）
